Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Iovance Biotherapeutics Plans Production Facility at Philadelphia Navy Yard
Iovance Biotherapeutics entered into a lease agreement in May of 2019 to construct a 136,000-sf facility at the Philadelphia Navy Yard. Featuring modular processes for optimal scalability, the building will support commercial and clinical production of therapeutics based on tumor-infiltrating lymphocyte (TIL) technologies. The $125 million facility is slated for completion in mid-2021. Iovance will contribute approximately $75 million towards the cost of the building over three years for equipment and construction of the manufacturing suites.
Seattle University Breaks Ground on Center for Science and Innovation
Seattle University broke ground in May of 2019 on the $115 million Center for Science and Innovation. Designed by EYP Architecture and Engineering and Mithūn Image, the five-story, 111,000-sf facility will house the College of Science and Engineering's programs in biology, chemistry, and computer science.
Siemens Launches Smart Manufacturing Innovation Center Chengdu
Siemens officially launched the Smart Manufacturing Innovation Center in May of 2019 in Chengdu, China. Located in the Chengdu High-tech Zone, the facility houses the Smart Manufacturing Center of Excellence, the Smart Manufacturing Professional Lab, the Industry Solutions Research Center, and the Talent Training Platform.
The Rockefeller University Dedicates Biomedical Research Campus
The Rockefeller University dedicated the $500 million Stavros Niarchos Foundation–David Rockefeller River Campus in May of 2019 in New York. The 160,000-sf complex features the $300 million, 135,600-sf Marie-Josée and Henry R. Kravis Research Building which provides flexible labs, two amphitheaters, offices, conference rooms, a dining area, and outdoor terraces. The two-story, horizontally oriented structure was designed to enhance collaboration and can support over 600 scientific staff.
Chugai Pharmaceuticals Builds Yokohama R&D Center
Chugai Pharmaceuticals will begin construction in August of 2019 on a $1.15 billion research and development center in Yokohama, Japan. Consolidating two labs currently sited in Gotemba and Kamakura, the facility will support drug discovery including the creation of therapies based on next-generation antibodies and synthetic macrocycles, also known as middle molecules. The pharmaceutical research center will leverage leading-edge automation processes and artificial intelligence technologies to accelerate the delivery of innovative medicines to patients worldwide.